NCT04766853View on ClinicalTrials.gov

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

April 18, 2023

Study Completion Date

July 19, 2024

Conditions
Hearing Loss, SuddenHearing Loss, OtotoxicHearing Loss, Noise-InducedMeniere Disease
Interventions
DRUG

Dexamethasone

Dexamethasone 5mg/ml

DRUG

Hyaluronic acid

Hyaluronic Acid 20mg/2ml

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04766853 - Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss | Biotech Hunter | Biotech Hunter